MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-26-2026
22nd Century Group DIO Ratio 2011-2026 | XXII
Annual DIO Ratio 22nd Century Group
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114 | 81.3 | 51.8 | 47.9 | 30.4 | 27.8 | 32 | 43.5 | 69.2 | 88.8 | 109 | 1.51 K | 1.11 K | 6.61 K | 592 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.61 K | 27.8 | 701 |
Quarterly DIO Ratio 22nd Century Group
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.5 | 80.6 | 72.3 | - | 73.6 | 65.5 | 78.3 | - | 352 | 242 | 198 | - | 54.2 | 46.2 | 34.6 | - | 30.4 | 25.6 | 30.9 | - | 26.7 | 29.8 | 29 | - | 31.9 | 35 | 37.9 | - | 45.5 | 41.1 | 47.8 | - | 61.5 | 73.7 | - | - | - | - | - | - | 83.7 | - | - | - | 616 | - | - | - | 6.24 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.24 K | 25.6 | 306 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Verastem
VSTM
|
403 | $ 5.04 | -4.73 % | $ 349 M |  USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M |  Canada |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | USA |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
bluebird bio
BLUE
|
125 | - | - | $ 546 M | USA |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
102 | - | - | $ 789 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
46.7 | $ 12.41 | -11.1 % | $ 1.88 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
501 | $ 5.4 | -3.05 % | $ 866 M | USA |
 |
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | USA |
 |
Zai Lab Limited
ZLAB
|
110 | $ 18.0 | 2.8 % | $ 19.7 B |  China |